使用糖尿病和斋月风险计算器的个性化风险降低策略:叙述性审查
Bachar Afandi1, Mohammed Hassanein2, Mohamed Suliman3
1Endocrine Division, Tawam Hospital & UAE University, AlAin, UAE.
Journal of diabetes and metabolic disorders
|December 30, 2024
概括
糖尿病和斋月风险计算器有助于评估禁食期间糖尿病风险. 该工具确定了可修改的因素,允许在斋月期间采取干预措施来降低风险并改善糖尿病管理.
科学领域:
- 糖尿病管理 糖尿病管理
- 公共卫生 公共卫生
- 医疗信息学 医疗信息学
背景情况:
- 斋月期间的禁食对糖尿病患者来说带来了独特的健康挑战.
- 评估和减轻与禁食相关的风险对于患者的安全和福祉至关重要.
- 现有的风险评估工具对于这一群体来说是有限的.
研究的目的:
- 介绍和讨论糖尿病和斋月风险计算器作为定量风险评估的工具.
- 探索修改计算器识别的风险因素的策略.
- 审查降低糖尿病患者禁食相关风险的方法的演变.
主要方法:
- 开发和应用糖尿病和斋月风险计算器 (2021年推出).
- 识别可修改的风险因素,有助于与禁食相关的并发症.
- 审查针对这些可修改因素的干预策略.
主要成果:
- 该计算器为在斋月期间禁食的糖尿病患者提供了定量风险评分.
- 许多评估的风险因素可以通过有针对性的干预措施进行修改.
- 积极管理风险因素可以减少与禁食有关的风险.
结论:
- 糖尿病和斋月风险计算器是管理斋月期间糖尿病的重要创新.
- 专注于可修改的风险因素的全年干预措施可以提高安全性和结果.
- 个性化策略是实现糖尿病患者安全和精神满足的禁食的关键.
相关概念视频
Diabetes: Management and Pharmacotherapy
203
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
203
Stress Prevention and Stress Management Techniques VI
15
Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
15
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
101
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
101
Errors occurring during blood pressure monitoring
565
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
565
Pre-Procedural Guidelines for Assessing Blood Pressure
509
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
509
Hazard Ratio
62
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
62


